EGFR-G574V-ET1
(Plasmid
#253821)
-
PurposeExpression of full length EGFR with G574V mutation
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 253821 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepET1
-
Vector typeMammalian Expression ; pIRES2-EGFP
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameEGFR with G574V mutation
-
SpeciesH. sapiens (human)
-
MutationG574V
-
Entrez GeneEGFR (a.k.a. ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS, PIG61, mENA)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
EGFR-G574V-ET1 was a gift from Timothy Springer (Addgene plasmid # 253821 ; http://n2t.net/addgene:253821 ; RRID:Addgene_253821) -
For your References section:
Nanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations. Watson SM, Harvey EP, Pishesha N, Ploegh HL, Springer TA. J Biol Chem. 2025 Jul;301(7):110374. doi: 10.1016/j.jbc.2025.110374. 10.1016/j.jbc.2025.110374 PubMed 40516870